<DOC>
	<DOCNO>NCT01479907</DOCNO>
	<brief_summary>The aim double-blinded prospective randomise trial explore potential benefit early postoperative administration Synbiotics ( combination prebiotics probiotic ) patient undergone colectomy cancer . The patient randomise either synbiotics placebo administration day able tolerate po liquid diet 15 day thereafter . Primary end point study : Assessment gastrointestinal function-related quality life 1 , 3 6 month postoperatively use validated questionnaire GIQLI ( Gastrointestinal Quality Life Index ) Secondary end point : -Assessment functional bowel disorder ( diarrhea , constipation , etc ) 1 , 3 6 month postoperatively base respective domain validate instrument EORTC QLQ-C30</brief_summary>
	<brief_title>Synbiotics Gastrointestinal Function Related Quality Life After Colectomy Cancer</brief_title>
	<detailed_description>The study patient randomize surgery receive either synbiotics ( Synbiotics group ) placebo ( Control group ) . Equal randomization accomplish use computer-generated random allocation schedule . The method allocation concealment sequentially number seal opaque envelope technique . Both synbiotics placebo preparation foil-sealed sachet store identical numbered container . Both study product white powder , identical weight , smell , taste . Thus , identity specific product blind participant , support staff investigator entire duration study period .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Colectomy histologically proven colorectal adenocarcinoma Pregnancy , hereditary cancer , history inflammatory bowel disease , metastatic disease presentation , emergency operation , major postoperative complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>